Medicine, Endocrinology Division

Grants

Grants per year 1999 2009 2012 2016 2026

• 58 Active
• 320 Finished

Grants per year

Search results

• Scaffold-Based Delivery of HIF-1 Alpha to Enhance Islet Transplantation

  Lowe Jr, W. L. & El Muayed, M.

  JDRF International

  9/1/08 → 8/31/10

  Project: Research project

• Chemical and Genetic Manipulation of Circadian Systems (Project 1 - Takahashi)

  Ferster, D. L., Vitaterna, M. H. & Hong, H.

  National Institute of Mental Health

  9/15/05 → 7/31/10

  Project: Research project

  • Circadian Clocks 100%
  • Circadian Rhythm 63%
  • Casein Kinase Iepsilon 39%
  • Systems Integration 28%
  • Suprachiasmatic Nucleus 25%

• Chemical and Genetic Manipulation of Circadian Systems (Holding Account)

  Ferster, D. L., Vitaterna, M. H., Ferster, D. L. & Hong, H.

  National Institute of Mental Health

  9/15/05 → 7/31/10

  Project: Research project

  • Circadian Clocks 100%
  • Circadian Rhythm 63%
  • Casein Kinase Iepsilon 39%
  • Systems Integration 28%
  • Suprachiasmatic Nucleus 25%

• Chemical and Genetic Manipulation of Circadian Systems (Biomath/Engineering Core)

  Ferster, D. L., Ferster, D. L., Vitaterna, M. H. & Hong, H.

  National Institute of Mental Health

  9/15/05 → 7/31/10

  Project: Research project

  • Circadian Clocks 100%
  • Circadian Rhythm 63%
  • Casein Kinase Iepsilon 39%
  • Systems Integration 28%
  • Suprachiasmatic Nucleus 25%

• Prot# ARD-0403-004: A Phase III Open-Label Study of the Efficacy and Safety of ARD-0403, a Testosterone Cream, in Testosterone Deficient Men

  Molitch, M. E.

  Ardana plc

  7/17/07 → 7/17/10

  Project: Research project

• Prot# ARD-0705-001: A Multi-Center, Randomized, Cross-Over Study Investigating a New, Oral Growth Hormone Secretagogue (GHS) (ARD-07) as a Growth Hormone (GH) Stimulation Test In Terms Of Safety and Efficacy Compared To L- ARG+GHRH.

  Molitch, M. E.

  Ardana plc

  7/17/07 → 7/17/10

  Project: Research project

• (BARI 2D) Data Coordinating Center - (Industry Funding / GSK)

  Davidson, C. J., Davidson, C. J. & Molitch, M. E.

  University of Pittsburgh, GlaxoSmithKline plc

  11/1/00 → 6/30/10

  Project: Research project

• Contribution of Circadian Rhythms Alterations to the Pathogenesis of Metabolic Syndrome

  Bass, J.

  Association de Langue Française pour l'Étude du Diabète et des Maladies Métaboliques

  6/1/09 → 5/31/10

  Project: Research project

• The Role of the Novel Anti-Inflammatory Molecule Surfactant Protein D in Pancreatic Beta Cells

  Lowe Jr, W. L. & Layden, B. T.

  Endocrine Fellows Foundation

  6/1/09 → 5/31/10

  Project: Research project

• Prot # 808676: The Testosterone Trial

  Molitch, M. E.

  University of Pennsylvania, Solvay Pharmaceuticals, Inc.

  5/15/09 → 4/30/10

  Project: Research project

• Training Program in Reproductive Biology

  Dunaif, A. E., Goldberg, E., Linzer, D. I., Mayo, K. E., Turek, F. W., Woodruff, T. K., Woolley, C. S., Dunaif, A. E., Goldberg, E., Linzer, D. I., Mayo, K. E., Turek, F. W., Woodruff, T. K. & Woolley, C. S.

  National Institute of Child Health and Human Development

  5/1/04 → 4/30/10

  Project: Research project

• Prot# MS315: A Multi-Center, Open Label Study to Assess the Ability of Subjects with Acromegaly, or Their Partners, to Administer Somatuline® Autogel®

  Molitch, M. E.

  Tercica, Inc.

  4/11/07 → 4/11/10

  Project: Research project

• Hyperglycemia and Adverse Pregnancy Outcome (HAPO)

  Metzger, B. E.

  National Institute of Child Health and Human Development

  4/5/04 → 2/28/10

  Project: Research project

  • Pregnancy Outcome 100%
  • Hyperglycemia 90%
  • Third Pregnancy Trimester 49%
  • Glucose 38%
  • Pregnancy 37%

• Hyperglycemia and Adverse Pregnancy Outcome (HAPO)

  Metzger, B. E.

  National Institute of Child Health and Human Development

  4/5/04 → 2/28/10

  Project: Research project

  • Pregnancy Outcome 100%
  • Hyperglycemia 90%
  • Third Pregnancy Trimester 49%
  • Glucose 38%
  • Pregnancy 37%

• Hyperglycemia and Adverse Pregnancy Outcome (HAPO)

  Metzger, B. E.

  National Institute of Child Health and Human Development

  4/5/04 → 2/28/10

  Project: Research project

  • Pregnancy Outcome 100%
  • Hyperglycemia 90%
  • Third Pregnancy Trimester 49%
  • Glucose 38%
  • Pregnancy 37%

• Hyperglycemia and Adverse Pregnancy Outcome (HAPO)

  Metzger, B. E.

  National Institute of Child Health and Human Development

  4/5/04 → 2/28/10

  Project: Research project

  • Pregnancy Outcome 100%
  • Hyperglycemia 90%
  • Third Pregnancy Trimester 49%
  • Glucose 38%
  • Pregnancy 37%

• Hyperglycemia and Adverse Pregnancy Outcome (HAPO)

  Metzger, B. E., Dooley, S. L. & Lowe, L. P.

  National Institute of Child Health and Human Development

  4/5/04 → 2/28/10

  Project: Research project

  • Pregnancy Outcome 100%
  • Hyperglycemia 90%
  • Third Pregnancy Trimester 49%
  • Glucose 38%
  • Pregnancy 37%

• Hyperglycemia and Adverse Pregnancy Outcome (HAPO): Hong Kong

  Metzger, B. E., Dooley, S. L. & Lowe, L. P.

  National Institute of Child Health and Human Development

  4/5/04 → 2/28/10

  Project: Research project

  • Pregnancy Outcome 100%
  • Hyperglycemia 90%
  • Hong Kong 62%
  • Third Pregnancy Trimester 49%
  • Glucose 38%

• Hyperglycemia and Adverse Pregnancy Outcome (HAPO): Thailand

  Metzger, B. E.

  National Institute of Child Health and Human Development

  4/5/04 → 2/28/10

  Project: Research project

  • Pregnancy Outcome 100%
  • Hyperglycemia 90%
  • Thailand 61%
  • Third Pregnancy Trimester 49%
  • Glucose 38%

• HAPO: Data Coordinating Center

  Dyer, A. R., Lowe, L. P. & Metzger, B. E.

  National Institute of Child Health and Human Development

  4/5/04 → 2/28/10

  Project: Research project

  • Pregnancy Outcome 100%
  • Hyperglycemia 90%
  • Third Pregnancy Trimester 49%
  • Glucose 38%
  • Pregnancy 37%

• Hyperglycemia and Adverse Pregnancy Outcome (HAPO)

  Metzger, B. E.

  National Institute of Child Health and Human Development

  4/5/04 → 2/28/10

  Project: Research project

  • Pregnancy Outcome 100%
  • Hyperglycemia 90%
  • Third Pregnancy Trimester 49%
  • Glucose 38%
  • Pregnancy 37%

• Hyperglycemia and Adverse Pregnancy Outcome (HAPO): Newcastle

  Metzger, B. E.

  National Institute of Child Health and Human Development

  4/5/04 → 2/28/10

  Project: Research project

  • Pregnancy Outcome 100%
  • Hyperglycemia 90%
  • Third Pregnancy Trimester 49%
  • Glucose 38%
  • Pregnancy 37%

• Hyperglycemia and Adverse Pregnancy Outcome (HAPO)

  Metzger, B. E.

  National Institute of Child Health and Human Development

  4/5/04 → 2/28/10

  Project: Research project

  • Pregnancy Outcome 100%
  • Hyperglycemia 90%
  • Third Pregnancy Trimester 49%
  • Glucose 38%
  • Pregnancy 37%

• Hyperglycemia and Adverse Pregnancy Outcome (HAPO)

  Metzger, B. E., Dooley, S. L. & Lowe, L. P.

  National Institute of Child Health and Human Development

  4/5/04 → 2/28/10

  Project: Research project

  • Pregnancy Outcome 100%
  • Hyperglycemia 90%
  • Third Pregnancy Trimester 49%
  • Glucose 38%
  • Pregnancy 37%

• Prot# 20010184: Trial to Reduce Cardiovascular Events with Aranesp® Therapy (TREAT Study)

  Molitch, M. E.

  Amgen, Inc.

  4/20/05 → 12/17/09

  Project: Research project